Clinical Factors Associated with the Therapeutic Outcome of Chemotherapy in Very Elderly Cancer Patients

Overview

Journal Int J Clin Oncol

Specialty Oncology

Date 2019 Jan 5

PMID 30607523

Citations 6

Authors

Satoko Ito

Haruyuki Ito

Noriyuki Sato

Yasuo Hirayama

Toshihiko Kusakabe

Takeshi Terui

Kunihiko Ishitani

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to detect background factors that might be associated with the therapeutic and curative outcome of chemotherapy in elderly cancer patients aged over 75 years.

Methods: A retrospective study was conducted for elderly cancer patients aged over 75 years who had received more than 2 courses of chemotherapy at our hospital. We analyzed the relationships between RECIST outcome and background factors, such as age, sex, clinical TNM stage, pre-treatment history, ECOG performance status, serum albumin, and Charlson comorbidity index using logistic regression analysis.

Results: A total of 103 cancer patients aged over 75 years were analyzed in this study, including 28 with hematological neoplasia, 36 with gastrointestinal tract cancers, 25 with breast cancers, and 14 with other malignancies originating in various tissues. Seventy-one patients (69.1%) had a positive clinical outcome including RECIST CR (complete response), PR (partial response) and SD (stable disease). Multivariate analysis showed that a high serum albumin level of more than 3.5 g/dl and a Charlson comorbidity index score of less than 2 points were positively correlated with a favorable therapeutic outcome.

Conclusions: The results of the current study suggested that serum albumin level and comorbidity index are the principal clinical factors affecting therapeutic outcomes in elderly cancer patients receiving chemotherapy. In the future, these factors may make chemotherapy adaptations, continuity, and effectiveness easier to predict than GA screening.

Citing Articles

Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy.

Wang X, Allen M, Espin-Garcia O, Suzuiki C, Bach Y, Panov E Oncologist. 2024; 29(11):e1501-e1510.

PMID: 39046894 PMC: 11546644. DOI: 10.1093/oncolo/oyae190.

Albumin‑bilirubin grade is an independent prognostic factor for small lung cell cancer.

Liu S, Zhao Q, Wang Z, Zhao B, Zhang X Mol Clin Oncol. 2024; 20(2):12.

PMID: 38213660 PMC: 10777464. DOI: 10.3892/mco.2023.2710.

Anxiety is Associated With Geriatric Assessment Impairments and Reduced Quality of Life Among Older Adults With Colorectal Cancer: Results From the CARE Registry.

Hess D, Fowler M, Harmon C, Giri S, Williams G Clin Colorectal Cancer. 2023; 22(4):383-389.

PMID: 37743126 PMC: 10956033. DOI: 10.1016/j.clcc.2023.08.001.

Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis.

Choi Y, Choi C, Rhie S, Shin S Int J Environ Res Public Health. 2022; 19(15).

PMID: 35954563 PMC: 9368240. DOI: 10.3390/ijerph19159196.

Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy.

Nishi H, Ohta K, Kuramoto Y, Shigeishi H, Obayashi T, Yoshioka Y Sci Rep. 2022; 12(1):2483.

PMID: 35169215 PMC: 8847642. DOI: 10.1038/s41598-022-06485-0.

References

Sargent D, Goldberg R, JACOBSON S, Macdonald J, Labianca R, Haller D . A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001; 345(15):1091-7. DOI: 10.1056/NEJMoa010957. View

Alexandre J, Gross-Goupil M, Falissard B, Nguyen M, Gornet J, Misset J . Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol. 2002; 14(1):36-41. DOI: 10.1093/annonc/mdg013. View

Lis C, Grutsch J, Vashi P, Lammersfeld C . Is serum albumin an independent predictor of survival in patients with breast cancer?. JPEN J Parenter Enteral Nutr. 2003; 27(1):10-5. DOI: 10.1177/014860710302700110. View

Chen H, Cantor A, Meyer J, Corcoran M, Grendys E, Cavanaugh D . Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003; 97(4):1107-14. DOI: 10.1002/cncr.11110. View

Carreca I, Balducci L, Extermann M . Cancer in the older person. Cancer Treat Rev. 2005; 31(5):380-402. DOI: 10.1016/j.ctrv.2005.04.012. View

Christman K, Muss H, Case L, Stanley V . Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. JAMA. 1992; 268(1):57-62. View

Extermann M, Aapro M, Bernabei R, Cohen H, Droz J, Lichtman S . Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005; 55(3):241-52. DOI: 10.1016/j.critrevonc.2005.06.003. View

Hurria A, Gupta S, Zauderer M, Zuckerman E, Cohen H, Muss H . Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005; 104(9):1998-2005. DOI: 10.1002/cncr.21422. View

Neugut A, Matasar M, Wang X, McBride R, Jacobson J, Tsai W . Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol. 2006; 24(15):2368-75. DOI: 10.1200/JCO.2005.04.5005. View

10.

Boonpipattanapong T, Chewatanakornkul S . Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006; 40(7):592-5. DOI: 10.1097/00004836-200608000-00006. View

11.

Onate-Ocana L, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, Carrillo J . Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2006; 14(2):381-9. DOI: 10.1245/s10434-006-9093-x. View

12.

Extermann M . Interaction between comorbidity and cancer. Cancer Control. 2007; 14(1):13-22. DOI: 10.1177/107327480701400103. View

13.

Siddiqui A, Heinzerling J, Livingston E, Huerta S . Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg. 2007; 194(3):362-6. DOI: 10.1016/j.amjsurg.2007.02.007. View

14.

Asmis T, Ding K, Seymour L, Shepherd F, Leighl N, Winton T . Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol. 2008; 26(1):54-9. DOI: 10.1200/JCO.2007.12.8322. View

15.

Droz J, Balducci L, Bolla M, Emberton M, Fitzpatrick J, Joniau S . Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int. 2010; 106(4):462-9. PMC: 3258484. DOI: 10.1111/j.1464-410X.2010.09334.x. View

16.

Pal S, Hurria A . Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol. 2010; 28(26):4086-93. DOI: 10.1200/JCO.2009.27.0579. View

17.

Temel J, Greer J, Muzikansky A, Gallagher E, Admane S, Jackson V . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363(8):733-42. DOI: 10.1056/NEJMoa1000678. View

18.

Hurria A, Togawa K, Mohile S, Owusu C, Klepin H, Gross C . Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011; 29(25):3457-65. PMC: 3624700. DOI: 10.1200/JCO.2011.34.7625. View

19.

Extermann M, Boler I, Reich R, Lyman G, Brown R, DeFelice J . Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2011; 118(13):3377-86. DOI: 10.1002/cncr.26646. View

20.

Puts M, Hardt J, Monette J, Girre V, Springall E, Alibhai S . Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst. 2012; 104(15):1133-63. PMC: 3413614. DOI: 10.1093/jnci/djs285. View